Product
Emcitate®
PHARMACEUTICAL
byEgetis Therapeutics
Sweden
ABOUT THE PRODUCT
Emcitate® (tiratricol) is our lead product candidate, a treatment for MCT8 deficiency (Allan-Herndon-Dudley syndrome).
Information is owner-confirmed
Last updated 1 week ago
Price range